Main Session
Sep
28
SS 05 - Lung 1: NSCLC Locally Advanced and Oligometastatatic
127 - Mid-Treatment ctDNA to Predict Outcomes in Stage IIB-IIIC NSCLC Treated with MRI-Adapted Chemoradiation
Presenter(s)
Ayesha Hashmi, MD - Mayo Clinic Alix School of Medicine, Rochester, MN